Startup based in the United States, most recent round Series A, 1 tracked investor.
Vilya is a company founded in 2022 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Vilya is a computational biotechnology company that uses advanced machine learning and AI-driven design to create novel macrocyclic drugs targeting disease biology, aiming to design new molecular structures not found in nature to precisely address previously intractable medical challenges.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.